Omnia SanaPlant Comparison
Oyster mushroom vs Dog-rose
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Oyster mushroom and Dog-rose: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Oyster mushroom | Dog-rose | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 10/10 | Stronger for Dog-rose |
| Cancer (anticancer research) | 8/10 | 2/10 | Stronger for Oyster mushroom |
| Inflammation (general) | 5/10 | 8/10 | Stronger for Dog-rose |
| Metabolic support | 6/10 | 7/10 | Comparable evidence |
| Skin irritation | 5/10 | 7/10 | Stronger for Dog-rose |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal bioactive constituents, responsible for most of the mushroom's immunomodulatory and anticancer activity.
Contribute to immunomodulatory activity alongside the pure beta-glucans.
Contribute to the antioxidant activity of the fruiting body.
The hip is exceptionally rich in vitamin C and carotenoids, underpinning its traditional tonic use. Quantified in commercial dried fruit at beta-carotene 7.25 mg/100 g and lycopene 2.34 mg/100 g fresh weight.
A specific galactolipid fraction studied as the likely active anti-inflammatory constituent in osteoarthritis trials of standardised rosehip powder.
Contribute to antioxidant activity. Leaves carry a higher total phenolic, flavonoid and phenolic-acid content than the hips, and leaf infusions were the only preparation to show antibacterial activity in vitro.
Cold-pressed rose hip seed oil is high in linolenic acid, with phytosterols up to 6485 mg/kg, tocopherols up to 1125 mg/kg and carotenoids up to 108 mg/kg; p-coumaric acid methyl ester predominates among its phenolics.
Pharmacological Actions
In vitro, the lipophilic (n-hexane and dichloromethane) rose hip extracts inhibited COX-1, COX-2 and 5-LOX-mediated leukotriene B4 formation; the aqueous and methanol extracts were inactive.
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Two placebo-controlled crossover RCTs of standardised rosehip powder (5 g/day) report reduced WOMAC pain and reduced rescue-medication use in knee/hip osteoarthritis, consistent with the existing meta-analysis.
inferred from anticancer action
Animal evidence only. In high-fat-diet/streptozotocin diabetic rats, R. canina ethanol extract (250 mg/kg) improved recall and long-term memory and reduced hippocampal insulin resistance, amyloid-beta and acetylcholinesterase activity. No human data; the effect is reported in a diabetes model, not in healthy or cognitively impaired people.
inferred from anti-inflammatory action
inferred from anti-inflammatory action
One triple-blind placebo-controlled RCT (n=400) found that 500 mg R. canina fruit capsules twice daily for 20 days after caesarean section reduced the incidence of urinary tract infection. The incidence of cystitis specifically did not differ significantly between groups. Prevention in a post-surgical population; not evidence for treating an established UTI.
Safety, Cautions & Contraindications
Generally very safe as a food. Rare cases of occupational asthma and allergy reported among people working with mushroom cultivation. Safe for culinary use without significant known interactions.
Rosa canina (dog rose) hips are generally recognized as safe (GRAS) for consumption, widely used in teas, jams, and supplements. They are highly nutritious but may cause minor digestive upset (nausea, diarrhea) in some users. The small, irritating hairs around the seeds should be removed before consumption.
Duke (2002) rates dog rose hips as +++ with clinical evidence (score 2) for astringent activity and experimental support for antioxidant and diuretic effects. Dog rose hips are exceptionally rich in vitamin C and bioflavonoids. They are traditionally used for cold and influenza prevention, urinary tract health, and mild diarrhea. Duke notes the diuretic (score 1) and lipoxygenase-inhibitory activities as experimentally documented. The fruit is considered food-grade safe (Duke, 2002).
External Ids
Botanical Description
Wood-decay fungus (not a true plant, Pleurotaceae) that grows in shelf-like, overlapping clusters on dead or dying hardwood trees and stumps. Fan- or oyster-shell-shaped caps, 5-25 cm across, are usually grey, tan or brown (occasionally pale or white), with white gills running down a short, off-centre stem. The mycelium is a fine white network that colonises and decomposes the wood substrate before fruiting.
Scrambling, thorny deciduous shrub (Rosaceae), 1-5 m, with arching, prickly stems bearing hooked thorns. Leaves are pinnate with 5-7 oval, toothed leaflets. Pale pink to white, five-petalled flowers are followed by bright red-orange, egg-shaped hips (the fleshy hip is an accessory fruit; the true fruits are small hairy achenes inside it) that ripen in autumn and often persist into winter.[2]
Habitat
Grows naturally on dead or dying broadleaf (hardwood) trees - beech, oak, poplar and others - in temperate forests worldwide; widely cultivated commercially on straw, sawdust and other lignocellulosic substrates.
Native throughout Europe, north-west Africa and western Asia, common in hedgerows, woodland edges, scrub and roadside verges on a wide range of soils.[2]
Harvesting
Wild fruiting bodies are picked as the caps mature but before they become tough or insect-damaged; cultivated mushrooms are harvested from substrate blocks or bags once the caps have expanded but before releasing significant spore load. Never forage a white shelf-fungus from wood without confirming the host tree, since the fatal Angel Wing look-alike is specific to conifer (softwood) wood.[14]
Hips are picked in autumn once fully coloured, then dried for tea or powder, or processed fresh for syrup. The fine, irritant hairs surrounding the seeds inside the hip must be removed before consumption.[5]
Traditional Uses
Oyster mushroom is a widely eaten culinary mushroom with a growing modern reputation as a medicinal fungus, valued for immune support and general wellbeing. Contemporary research on its beta-glucan polysaccharides supports immunomodulatory, antioxidant, anticancer and cardiometabolic activity.[1, 5]
Rosehip has a long European folk tradition as a vitamin-C-rich tonic for colds and general immunity, and as a mild diuretic and astringent for urinary and digestive complaints. Modern clinical trials on standardised rosehip powder show a modest, reproducible benefit for osteoarthritis pain and stiffness.[1, 2]
Preparations
Dosage
Clinical trials for osteoarthritis have most often used around 5 g/day of standardised rosehip powder. Educational reference only, not a prescription.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Motta, F., Gershwin, M.E. and Selmi, C (2021) 'Mushrooms and immunity', Journal of Autoimmunity, 117, pp. 102576. doi:10.1016/j.jaut.2020.102576 Meta-analysis / review
https://doi.org/10.1016/j.jaut.2020.102576 - Toros, G., El-Ramady, H., Prokisch, J., Velasco, F. and others (2023) 'Modulation of the Gut Microbiota with Prebiotics and Antimicrobial Agents from Pleurotus ostreatus Mushroom', Foods, 12(10), pp. 2010. doi:10.3390/foods12102010 Preclinical
https://doi.org/10.3390/foods12102010 - Mishra, V., Tomar, S., Yadav, P. and Singh, M.P (2021) 'Promising anticancer activity of polysaccharides and other macromolecules derived from oyster mushroom (Pleurotus sp.): An updated review', International Journal of Biological Macromolecules, 182, pp. 1628-1637. doi:10.1016/j.ijbiomac.2021.05.102 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2021.05.102 - Gu, Y.H. and Sivam, G (2006) 'Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells', Journal of Medicinal Food, 9(2), pp. 196-204. doi:10.1089/jmf.2006.9.196 Preclinical
https://doi.org/10.1089/jmf.2006.9.196 - Sharma, A., Sharma, A. and Tripathi, A (2021) 'Biological activities of Pleurotus spp. polysaccharides: A review', Journal of Food Biochemistry, 45(6), pp. e13748. doi:10.1111/jfbc.13748 Meta-analysis / review
https://doi.org/10.1111/jfbc.13748 - Krupodorova, T., Barshteyn, V., Tsygankova, V., Sevindik, M. and others (2024) 'Strain-specific features of Pleurotus ostreatus growth in vitro and some of its biological activities', BMC Biotechnology, 24(1), pp. 9. doi:10.1186/s12896-024-00834-9 Preclinical
https://doi.org/10.1186/s12896-024-00834-9 - Perez-Bassart, Z., Bauerl, C., Fabra, M.J., Martinez-Abad, A. and others (2023) 'Composition, structural properties and immunomodulatory activity of several aqueous Pleurotus beta-glucan-rich extracts', International Journal of Biological Macromolecules, 253(Pt 6), pp. 127255. doi:10.1016/j.ijbiomac.2023.127255 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.127255 - Dos Santos, J.F., de Oliveira, N.M.T., da Silva Milhorini, S., Rutckeviski, R. and others (2025) 'The use of Pleurotus ostreatus by-products for the preparation of a gel-like polysaccharide with bioactive properties', International Journal of Biological Macromolecules, 301, pp. 140236. doi:10.1016/j.ijbiomac.2025.140236 Preclinical
https://doi.org/10.1016/j.ijbiomac.2025.140236 - Huang, X. and Nie, S (2015) 'The structure of mushroom polysaccharides and their beneficial role in health', Food & Function, 6(10), pp. 3205-3217. doi:10.1039/c5fo00678c Meta-analysis / review
https://doi.org/10.1039/c5fo00678c - Drezek, J. and Mozejko-Ciesielska, J (2025) 'Production of beta-Glucans by Pleurotus ostreatus: Cultivation and Genetic Background', International Journal of Molecular Sciences, 26(19), pp. 9703. doi:10.3390/ijms26199703 Preclinical
https://doi.org/10.3390/ijms26199703 - Spacek, J., Vocka, M., Zavadova, E., Konopasek, B. and Petruzelka, L (2021) 'Immunomodulation with beta-glucan from Pleurotus ostreatus in patients with endocrine-dependent breast cancer', Immunotherapy, 14(1), pp. 31-40. doi:10.2217/imt-2021-0069 Clinical study
https://doi.org/10.2217/imt-2021-0069 - Majtan, J (2012) 'Pleuran (beta-glucan from Pleurotus ostreatus): an effective nutritional supplement against upper respiratory tract infections?', Medicine and Sport Science, 59, pp. 57-61. doi:10.1159/000341967 Clinical study
https://doi.org/10.1159/000341967 - Gariboldi, M.B., Marras, E., Ferrario, N., Vivona, V., Prini, P., Vignati, F. and Perletti, G (2023) 'Anti-Cancer Potential of Edible/Medicinal Mushrooms in Breast Cancer', International Journal of Molecular Sciences, 24(12), pp. 10120. doi:10.3390/ijms241210120 Preclinical
https://doi.org/10.3390/ijms241210120 - Gonmori, K. and Yokoyama, K (2009) 'Acute encephalopathy caused by cyanogenic fungi in 2004, and magic mushroom regulation in Japan', Chudoku Kenkyu, 22(1), pp. 61-9. Available at: https://pubmed.ncbi.nlm.nih.gov/19344063/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/19344063/ - Wasser, S.P (2011) 'Current findings, future trends, and unsolved problems in studies of medicinal mushrooms', 89(5), pp. 1323--1332. doi:10.1007/s00253-010-3067-4 Randomized trial
https://doi.org/10.1007/s00253-010-3067-4 - Guillamon, E. et al (2010) 'Edible mushrooms: role in the prevention of cardiovascular diseases', 81(7), pp. 715--723. doi:10.1016/j.fitote.2010.06.005 Clinical study
https://doi.org/10.1016/j.fitote.2010.06.005 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Yamamoto, N. and Suzuki, T. and Kobayashi, M. and others (2014) 'A-WINGS: an integrated genome database for Pleurocybella porrigens (angel's wing oyster mushroom, Sugihiratake)', BMC Research Notes, 7, pp. 866. doi:10.1186/1756-0500-7-866 Preclinical
https://doi.org/10.1186/1756-0500-7-866 - Mushroom Appreciation (2024) 'Angel wings vs oyster mushrooms: identification and controversy'. Available at: https://www.mushroom-appreciation.com/angel-wings-identification.html Traditional / reference
https://www.mushroom-appreciation.com/angel-wings-identification.html - Sugano, Y. and Sakata, K. and Nakamura, K. and others (2017) 'Rapid identification method of Omphalotus japonicus by PCR-RFLP', Shokuhin Eiseigaku Zasshi, 58(3), pp. 113-123. doi:10.3358/shokueishi.58.113 Preclinical
https://doi.org/10.3358/shokueishi.58.113 - Kasahara, Y (2013) 'Clinical toxicology of mushroom poisoning: Omphalotus guepiniformis', Chudoku Kenkyu, 26(3), pp. 215-8. Available at: https://pubmed.ncbi.nlm.nih.gov/24224384/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/24224384/ - Mushroom Appreciation (2024) 'The jack o'lantern mushroom (Omphalotus olearius)'. Available at: https://www.mushroom-appreciation.com/omphalotus-olearius.html Traditional / reference
https://www.mushroom-appreciation.com/omphalotus-olearius.html
- Christensen, R., Bartels, E.M., Altman, R.D., Astrup, A. and Bliddal, H (2008) 'Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? - a meta-analysis of randomized controlled trials', Osteoarthritis and Cartilage, 16(9), pp. 965-972. doi:10.1016/j.joca.2008.03.001 Meta-analysis / review
https://doi.org/10.1016/j.joca.2008.03.001 - Gruenwald, J., Uebelhack, R. and More, M.I (2019) 'Rosa canina - Rose hip pharmacological ingredients and molecular mechanics counteracting osteoarthritis - A systematic review', Phytomedicine, 60, pp. 152958. doi:10.1016/j.phymed.2019.152958 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2019.152958 - Sanz-Lamora, H., Nicola-Llorente, M., Torres-Oteros, D., Perez-Marti, A. and others (2024) 'The Antiobesity Effects of Rosehip (Rosa canina) Flesh by Antagonizing the PPAR Gamma Activity in High-Fat Diet-Fed Mice', Molecular Nutrition & Food Research, 68(5), pp. e2300539. doi:10.1002/mnfr.202300539 Preclinical
https://doi.org/10.1002/mnfr.202300539 - Tumbas, V.T., Canadanovic-Brunet, J.M., Cetojevic-Simin, D.D., Cetkovic, G.S. and others (2011) 'Effect of rosehip (Rosa canina L.) phytochemicals on stable free radicals and human cancer cells', Journal of the Science of Food and Agriculture, 92(6), pp. 1273-1281. doi:10.1002/jsfa.4695 Preclinical
https://doi.org/10.1002/jsfa.4695 - Pena, F., Valencia, S., Tereucan, G., Nahuelcura, J. and others (2023) 'Bioactive Compounds and Antioxidant Activity in the Fruit of Rosehip (Rosa canina L. and Rosa rubiginosa L.)', Molecules, 28(8), pp. 3544. doi:10.3390/molecules28083544 Preclinical
https://doi.org/10.3390/molecules28083544 - Hendrysiak, A., Brzezowska, J., Nicolet, N., Bocquel, D. and others (2023) 'Juice Powders from Rosehip (Rosa canina L.): Physical, Chemical, and Antiglycation Properties', Molecules, 28(4), pp. 1674. doi:10.3390/molecules28041674 Preclinical
https://doi.org/10.3390/molecules28041674 - Igual, M., Garcia-Herrera, P., Camara, R.M., Martinez-Monzo, J. and others (2022) 'Bioactive Compounds in Rosehip (Rosa canina) Powder with Encapsulating Agents', Molecules, 27(15), pp. 4737. doi:10.3390/molecules27154737 Preclinical
https://doi.org/10.3390/molecules27154737 - Truong, V.L. and Jeong, W.S (2023) 'Hair Growth-Promoting Effects of Rosehip (Rosa canina L.) Seed Oil in C57BL/6 Mice', Preventive Nutrition and Food Science, 28(4), pp. 411-417. doi:10.3746/pnf.2023.28.4.411 Preclinical
https://doi.org/10.3746/pnf.2023.28.4.411 - Michalska-Ciechanowska, A., Brzezowska, J., Nicolet, N., Haladyn, K. and others (2025) 'Valorization of Rosehip (Rosa canina L.) Pomace Using Unconventional Carbohydrate Carriers for Beverage Obtainment', Molecules, 30(1), pp. 141. doi:10.3390/molecules30010141 Preclinical
https://doi.org/10.3390/molecules30010141 - Vlaicu, P.A., Untea, A.E., Turcu, R.P., Panaite, T.D. and Saracila, M (2022) 'Rosehip (Rosa canina L.) Meal as a Natural Antioxidant on Lipid and Protein Quality and Shelf-Life of Polyunsaturated Fatty Acids Enriched Eggs', Antioxidants (Basel), 11(10), pp. 1948. doi:10.3390/antiox11101948 Preclinical
https://doi.org/10.3390/antiox11101948 - Phetcharat, L. and Wongsuphasawat, K. and Winther, K (2015) 'The effectiveness of a standardized rose hip powder, containing seeds and shells of Rosa canina, on cell longevity, skin wrinkles, moisture, and elasticity', Clinical Interventions in Aging, 10, pp. 1849--1856. doi:10.2147/CIA.S90092 Randomized trial
https://doi.org/10.2147/CIA.S90092 - Golsorkhi, H. and Montazerlotfelahi, H. and Abniki, E. and Vafaee-Shahi, M. and Kamalinejad, M. and Qorbani, M. and Bahrami, M. and Dadmehr, M (2025) 'Efficacy and safety of Rosa canina L. and a traditional polyherbal formulation syrup in children and adolescents with attention-deficit/hyperactivity disorder: a factorial randomized double-blind placebo-controlled clinical trial', Phytotherapy Research, 39(9), pp. 4116--4125. doi:10.1002/ptr.70061 Randomized trial
https://doi.org/10.1002/ptr.70061 - Miljkovi\'c, V. M. and Nikoli\'c, L. and Mrmo\v sanin, J. and Gaji\'c, I. and Mihajilov-Krstev, T. and Zvezdanovi\'c, J. and Miljkovi\'c, M (2024) 'Chemical profile and antioxidant and antimicrobial activity of Rosa canina L. dried fruit commercially available in Serbia', International Journal of Molecular Sciences, 25(5), pp. 2518. doi:10.3390/ijms25052518 Preclinical
https://doi.org/10.3390/ijms25052518 - Polumackanycz, M. and Kaszuba, M. and Konopacka, A. and Marzec-Wr\'oblewska, U. and Wesolowski, M. and Waleron, K. and Buci\'nski, A. and Viapiana, A (2020) 'Phenolic composition and biological properties of wild and commercial dog rose (Rosa canina L.) fruits and leaves', Molecules, 25(22), pp. 5272. doi:10.3390/molecules25225272 Preclinical
https://doi.org/10.3390/molecules25225272 - Grajzer, M. and Prescha, A. and Korzonek, K. and Wojakowska, A. and Dziadas, M. and Kulma, A. and Grajeta, H (2015) 'Characteristics of rose hip (Rosa canina L.) cold-pressed oil and its oxidative stability studied by the differential scanning calorimetry method', Food Chemistry, 188, pp. 459--466. doi:10.1016/j.foodchem.2015.05.034 Preclinical
https://doi.org/10.1016/j.foodchem.2015.05.034 - Chrubasik, C., Roufogalis, B.D., Müller-Ladner, U. and Chrubasik, S (2008) 'A systematic review on the Rosa canina effect and efficacy profiles', 22(6), pp. 725--733. doi:10.1002/ptr.2400 Meta-analysis / review
https://doi.org/10.1002/ptr.2400 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Wenzig, E. M. and Widowitz, U. and Kunert, O. and Chrubasik, S. and Bucar, F. and Knauder, E. and Bauer, R (2008) 'Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa canina L.) preparations', Phytomedicine, 15(10), pp. 826--835. doi:10.1016/j.phymed.2008.06.012 Preclinical
https://doi.org/10.1016/j.phymed.2008.06.012 - Winther, K. and Apel, K. and Thamsborg, G (2005) 'A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial', Scandinavian Journal of Rheumatology, 34(4), pp. 302--308. doi:10.1080/03009740510018624 Randomized trial
https://doi.org/10.1080/03009740510018624 - Rein, E. and Kharazmi, A. and Winther, K (2004) 'A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis: a double-blind, placebo-controlled, randomised trial', Phytomedicine, 11(5), pp. 383--391. doi:10.1016/j.phymed.2004.01.001 Randomized trial
https://doi.org/10.1016/j.phymed.2004.01.001 - Ertas, B. and Hazar-Yavuz, A. N. and Topal, F. and Keles-Kaya, R. and Karakus, \"O. and Ozcan, G. S. and Taskin, T. and Cam, M. E (2023) 'Rosa canina L. improves learning and memory-associated cognitive impairment by regulating glucose levels and reducing hippocampal insulin resistance in high-fat diet/streptozotocin-induced diabetic rats', Journal of Ethnopharmacology, 313, pp. 116541. doi:10.1016/j.jep.2023.116541 Preclinical
https://doi.org/10.1016/j.jep.2023.116541 - Seifi, M. and Abbasalizadeh, S. and Mohammad-Alizadeh-Charandabi, S. and Khodaie, L. and Mirghafourvand, M (2017) 'The effect of Rosa (L. Rosa canina) on the incidence of urinary tract infection in the puerperium: a randomized placebo-controlled trial', Phytotherapy Research, 32(1), pp. 76--83. doi:10.1002/ptr.5950 Randomized trial
https://doi.org/10.1002/ptr.5950 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.